These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 18719357)

  • 21. The differential impact of p16(INK4a) or p19(ARF) deficiency on cell growth and tumorigenesis.
    Sharpless NE; Ramsey MR; Balasubramanian P; Castrillon DH; DePinho RA
    Oncogene; 2004 Jan; 23(2):379-85. PubMed ID: 14724566
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Autophagy and caspase-independent cell death: p19ARF enters the game.
    Codogno P
    Dev Cell; 2006 Jun; 10(6):688-9. PubMed ID: 16740471
    [TBL] [Abstract][Full Text] [Related]  

  • 23. miR-34a is essential for p19(Arf)-driven cell cycle arrest.
    Iqbal N; Mei J; Liu J; Skapek SX
    Cell Cycle; 2014; 13(5):792-800. PubMed ID: 24401748
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Emerging roles of mitochondrial p53 and ARF.
    Itahana Y; Itahana K
    Curr Drug Targets; 2012 Dec; 13(13):1633-40. PubMed ID: 22998186
    [TBL] [Abstract][Full Text] [Related]  

  • 25. DNA damage-dependent translocation of B23 and p19 ARF is regulated by the Jun N-terminal kinase pathway.
    Yogev O; Saadon K; Anzi S; Inoue K; Shaulian E
    Cancer Res; 2008 Mar; 68(5):1398-406. PubMed ID: 18316603
    [TBL] [Abstract][Full Text] [Related]  

  • 26. p53-Dependent and -independent functions of the Arf tumor suppressor.
    Sherr CJ; Bertwistle D; DEN Besten W; Kuo ML; Sugimoto M; Tago K; Williams RT; Zindy F; Roussel MF
    Cold Spring Harb Symp Quant Biol; 2005; 70():129-37. PubMed ID: 16869746
    [TBL] [Abstract][Full Text] [Related]  

  • 27. C/EBPbeta represses p53 to promote cell survival downstream of DNA damage independent of oncogenic Ras and p19(Arf).
    Ewing SJ; Zhu S; Zhu F; House JS; Smart RC
    Cell Death Differ; 2008 Nov; 15(11):1734-44. PubMed ID: 18636078
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Nucleolar Arf sequesters Mdm2 and activates p53.
    Weber JD; Taylor LJ; Roussel MF; Sherr CJ; Bar-Sagi D
    Nat Cell Biol; 1999 May; 1(1):20-6. PubMed ID: 10559859
    [TBL] [Abstract][Full Text] [Related]  

  • 29. RNA helicase DDX5 is a p53-independent target of ARF that participates in ribosome biogenesis.
    Saporita AJ; Chang HC; Winkeler CL; Apicelli AJ; Kladney RD; Wang J; Townsend RR; Michel LS; Weber JD
    Cancer Res; 2011 Nov; 71(21):6708-17. PubMed ID: 21937682
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gain of function in the mouse model of a recurrent mutation p53
    Zhao L; Wang B; Zhao X; Wu X; Zhang Q; Wei C; Shi M; Li Y; Tang W; Zhang J; Yang J; Singh SK; Jia S; Luo Y
    Mol Carcinog; 2018 Feb; 57(2):147-158. PubMed ID: 28949402
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A non-tumor suppressor role for basal p19ARF in maintaining nucleolar structure and function.
    Apicelli AJ; Maggi LB; Hirbe AC; Miceli AP; Olanich ME; Schulte-Winkeler CL; Saporita AJ; Kuchenreuther M; Sanchez J; Weilbaecher K; Weber JD
    Mol Cell Biol; 2008 Feb; 28(3):1068-80. PubMed ID: 18070929
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Skp2 targeting suppresses tumorigenesis by Arf-p53-independent cellular senescence.
    Lin HK; Chen Z; Wang G; Nardella C; Lee SW; Chan CH; Yang WL; Wang J; Egia A; Nakayama KI; Cordon-Cardo C; Teruya-Feldstein J; Pandolfi PP
    Nature; 2010 Mar; 464(7287):374-9. PubMed ID: 20237562
    [TBL] [Abstract][Full Text] [Related]  

  • 33. p19(Arf) limits primary vitreous cell proliferation driven by PDGF-B.
    Iqbal NS; Devitt CC; Sung CY; Skapek SX
    Exp Eye Res; 2016 Apr; 145():224-229. PubMed ID: 26778750
    [TBL] [Abstract][Full Text] [Related]  

  • 34. p19(Arf) induces p53-dependent apoptosis during abelson virus-mediated pre-B cell transformation.
    Radfar A; Unnikrishnan I; Lee HW; DePinho RA; Rosenberg N
    Proc Natl Acad Sci U S A; 1998 Oct; 95(22):13194-9. PubMed ID: 9789064
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Two arginine rich domains in the p14ARF tumour suppressor mediate nucleolar localization.
    Rizos H; Darmanian AP; Mann GJ; Kefford RF
    Oncogene; 2000 Jun; 19(26):2978-85. PubMed ID: 10871849
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The inhibitor of cyclin-dependent kinase 4a/alternative reading frame (INK4a/ARF) locus encoded proteins p16INK4a and p19ARF repress cyclin D1 transcription through distinct cis elements.
    D'Amico M; Wu K; Fu M; Rao M; Albanese C; Russell RG; Lian H; Bregman D; White MA; Pestell RG
    Cancer Res; 2004 Jun; 64(12):4122-30. PubMed ID: 15205322
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Consistent inactivation of p19(Arf) but not p15(Ink4b) in murine myeloid cells transformed in vivo by deregulated c-Myc.
    Haviernik P; Schmidt M; Hu X; Wolff L
    Oncogene; 2003 Mar; 22(11):1600-10. PubMed ID: 12642863
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ubiquitination of, and sumoylation by, the Arf tumor suppressor.
    den Besten W; Kuo ML; Tago K; Williams RT; Sherr CJ
    Isr Med Assoc J; 2006 Apr; 8(4):249-51. PubMed ID: 16671360
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human p14(Arf): an exquisite sensor of morphological changes and of short-lived perturbations in cell cycle and in nucleolar function.
    David-Pfeuty T; Nouvian-Dooghe Y
    Oncogene; 2002 Oct; 21(44):6779-90. PubMed ID: 12360404
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MDM2-ARF complex regulates p53 sumoylation.
    Chen L; Chen J
    Oncogene; 2003 Aug; 22(34):5348-57. PubMed ID: 12917636
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.